Gustavo T. Corrêa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gustavo T. Corrêa has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Eduarda Carolina Amaral
Instituto de Pesquisa Pelé Pequeno Príncipe, Av. Munhoz da Rocha 490, Cabral, Curitiba 80035-000, PR, Brazil
1 shared publication - Fabio Seigi Murakami
Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná
1 shared publication - Juliana Campos Atherino
Laboratory of Bacteriology, Mycology and Molecular Biology, Departamento de Análises Clínicas, Federal University of Paraná, Curitiba 80210-170, Brazil
1 shared publication - Lauro Mera de Souza
Institute of Research Pelé Pequeno Príncipe, Pequeno Príncipe Faculty, Curitiba, Paraná, Brazil
1 shared publication - Leandro Lacerda Giacomin
Universidade Federal da Paraíba
1 shared publication - Leopoldo Clemente Baratto
Laboratory of Historical and Applied Studies in Pharmacognosy, Faculty of Pharmacy Universidade Federal do Rio de Janeiro (UFRJ) Rio de Janeiro RJ Brazil
1 shared publication
Latest Publications
- 8 November 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (1) , e02296
Chemical Profiles and Bioactivities of Brazilian Amazonian Solanum Species: Antioxidant, Cytotoxic, and Anti‐Metastatic Properties
This study investigated the chemical and biological properties of hydroethanolic extracts from Solanum asperum , Solanum crinitum , Solanum schlechtendalianum , Solanum stramoniifolium , and Solanum leucocarpon . Using ultra‐high‐performance liquid chromatography with electrospray ionization mass spectrometry and gas chromatography, 41 compounds and five monosaccharides were identified. Antioxidant activity was confirmed in all extracts through the DPPH radical scavenging assay, with S. schlechtendalianum showing the highest activity, consistent with its elevated total polyphenol (94.4 mg GAE/g) and flavonoid (46.8 mg QE/g) contents. The anticancer potential was assessed against human breast (MCF‐7, MDA‐MB‐231) and colorectal (HRT‐18) cancer cell lines using the MTT assay. Among the samples, S. crinitum exhibited the greatest cytotoxicity against HRT‐18 cells, with an IC 50 of 58 µg/mL and a selectivity index of 1.5, confirmed by clonogenic assays. Furthermore, S. crinitum significantly inhibited nitric oxide production (74%), cell migration (74%), and adhesion (52% and 30% on fibronectin and vitronectin, respectively), indicating notable anti‐metastatic potential. These results demonstrate that Solanum species, particularly S. crinitum and S. schlechtendalianum , are promising sources of bioactive compounds with antioxidant, anticancer, and anti‐metastatic properties, supporting their potential use in pharmaceutical and cosmetic industries.
- 8 November 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (1) , e02296
Chemical Profiles and Bioactivities of Brazilian Amazonian Solanum Species: Antioxidant, Cytotoxic, and Anti‐Metastatic Properties
This study investigated the chemical and biological properties of hydroethanolic extracts from Solanum asperum , Solanum crinitum , Solanum schlechtendalianum , Solanum stramoniifolium , and Solanum leucocarpon . Using ultra‐high‐performance liquid chromatography with electrospray ionization mass spectrometry and gas chromatography, 41 compounds and five monosaccharides were identified. Antioxidant activity was confirmed in all extracts through the DPPH radical scavenging assay, with S. schlechtendalianum showing the highest activity, consistent with its elevated total polyphenol (94.4 mg GAE/g) and flavonoid (46.8 mg QE/g) contents. The anticancer potential was assessed against human breast (MCF‐7, MDA‐MB‐231) and colorectal (HRT‐18) cancer cell lines using the MTT assay. Among the samples, S. crinitum exhibited the greatest cytotoxicity against HRT‐18 cells, with an IC 50 of 58 µg/mL and a selectivity index of 1.5, confirmed by clonogenic assays. Furthermore, S. crinitum significantly inhibited nitric oxide production (74%), cell migration (74%), and adhesion (52% and 30% on fibronectin and vitronectin, respectively), indicating notable anti‐metastatic potential. These results demonstrate that Solanum species, particularly S. crinitum and S. schlechtendalianum , are promising sources of bioactive compounds with antioxidant, anticancer, and anti‐metastatic properties, supporting their potential use in pharmaceutical and cosmetic industries.